Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000205187 | SCV000260055 | uncertain significance | Microcephaly, normal intelligence and immunodeficiency | 2022-08-15 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with arginine, which is basic and polar, at codon 276 of the NBN protein (p.Thr276Arg). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with NBN-related conditions. ClinVar contains an entry for this variant (Variation ID: 219906). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV000219109 | SCV000276771 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-10-25 | criteria provided, single submitter | clinical testing | The c.827C>G (p.T276R) alteration is located in exon 7 (coding exon 7) of the NBN gene. This alteration results from a C to G substitution at nucleotide position 827, causing the threonine (T) at amino acid position 276 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000759889 | SCV000889558 | uncertain significance | not provided | 2021-08-26 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000205187 | SCV002044775 | uncertain significance | Microcephaly, normal intelligence and immunodeficiency | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV004567459 | SCV005056110 | uncertain significance | Aplastic anemia | 2024-03-29 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000205187 | SCV001457047 | uncertain significance | Microcephaly, normal intelligence and immunodeficiency | 2020-01-24 | no assertion criteria provided | clinical testing |